‘Viral fusion’ fuels extra-potent vaccine for RSV, could be deployed for flu, researchers say
By
Aaron Dorman
Mar 19, 2024
A new “3D vaxlock” process creates a vaccine 11 times more potent than “standard industry comparators,” new research shows.
Tetanus vaccine may be in short supply after company stops production
Feb 29, 2024
Sanofi plans to ramp up production of its version, but doctors should switch to the Tdap shot in the meantime.
Bill would ban COVID-19 vaccine mandates despite older adults remaining at highest risk for serious outcomes
By
Kimberly Bonvissuto
Nov 02, 2023
A study underscoring the need to continue to protect older adults from COVID-19 comes as one state appears close to banning COVID-19 vaccine mandates by private employers, including senior living communities.
Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
In early trial, results promising for Moderna combo COVID-flu vaccine
Oct 05, 2023
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Employer COVID-19 vaccine mandates significantly increase uptake with little effect on staffing: study
By
Kimberly Bonvissuto
Aug 08, 2023
An employee mandate led to a “significant” increase in COVID-19 vaccine uptake with little effect on staffing in a multi-state network of continuing care retirement communities studied by researchers,...
New Jersey joins other states in lifting pandemic-related requirements for assisted living
By
Kimberly Bonvissuto
Jun 16, 2023
COVID-19 vaccination requirements for assisted living and healthcare employees have been lifted in New Jersey following recent changes to federal requirements surrounding the pandemic.
FDA approves first RSV vaccine
May 03, 2023
Arexvy was ~82% effective in preventing RSV-induced lower respiratory tract infections in adults aged 60 or more years.
Communication, documentation key in COVID litigation defense, legal experts say
By
Kimberly Bonvissuto
Oct 28, 2022
COVID-19 continues to challenge senior living and other long-term care providers on various levels. But the message from the legal field remains consistent: communicate and document.